Study of Oral MRT-2359 in Selected Cancer Patients
Monte Rosa Therapeutics, Inc
Monte Rosa Therapeutics, Inc
Incyte Corporation
OncoNano Medicine, Inc.
Incyte Corporation
Nurix Therapeutics, Inc.
Novartis
Seagen Inc.
Zumutor Biologics Inc.
Celldex Therapeutics
Eastern Cooperative Oncology Group
Celgene
Incyte Corporation
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Vanderbilt-Ingram Cancer Center
City of Hope Medical Center
Vanderbilt-Ingram Cancer Center
Wake Forest University Health Sciences
Seagen Inc.
Masonic Cancer Center, University of Minnesota
Wake Forest University Health Sciences
Fred Hutchinson Cancer Center
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
University of Louisville
OHSU Knight Cancer Institute
Fred Hutchinson Cancer Center
Rutgers, The State University of New Jersey
Columbia University
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Vanderbilt University
Indiana University
University of Minnesota
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mayo Clinic
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)